8-KThe WireRoutine
Reg FD Disclosure
Filed Jan 9, 2023 · 3y ago · Accession 0001193125-23-004150
Plain English
Material event — a significant development the company must disclose promptly.
Read the source below for the full document.
Filing details
- Company
- Spyre Therapeutics, Inc.
- Ticker
- SYRE
- CIK
- 1636282
- Form type
- 8-K
- Filing date
- Jan 9, 2023
- Report date
- Jan 9, 2023
- Document
- d423039d8k.htm
- Size
- 15.3 MB